Publication Details
Abstract
Objective: This study provides a comparative analysis of metabolic and inflammatory profiles in PCOS patients against approximate normal ranges. Method: Regarding hereditary diseases, thyroid gland issues were the most frequently reported (41.18%), followed by diabetes (35.29%), while a smaller proportion reported no hereditary diseases listed (23.53%). These findings provide insights into the prevalence of certain hereditary metabolic conditions within the studied group of PCOS patients. Results: The data reveals that, on average, PCOS patients exhibit elevated levels of CRP (10.74 ± 1.82 mg/L), total cholesterol (TC: 205.09 ± 4.81 mg/dL), triglycerides (TG: 205.09 ± 15.84 mg/dL), blood sugar (138.45 ± 7.87 mg/dL), and HbA1c (6.39 ± 0.268%), suggesting increased inflammation, dyslipidemia, and impaired glucose metabolism. Furthermore, vitamin D levels are markedly deficient in this group (9.64 ± 0.57 ng/mL). While hemoglobin (Hb) levels are within the lower end of the normal range (11.5 ± 0.315 g/dL), the average BMI of the PCOS patient group falls within the overweight category (29.58 ± 1.68 kg/m²). These findings highlight significant metabolic and inflammatory alterations in PCOS patients compared to established normal ranges. Finally, concludes that PCOS patients exhibit significant metabolic and inflammatory disturbances, including inflammation (elevated CRP), dyslipidemia (elevated TC and TG), impaired glucose metabolism (elevated blood sugar and HbA1c), and vitamin D deficiency. They also have a tendency towards being overweight. Furthermore, there is a notable prevalence of hereditary thyroid issues and diabetes within this group. These factors collectively contribute to an increased risk of cardiovascular disease and type 2 diabetes. We emphasize early detection of PCOS and implementation of strategies to address elevated CRP, cholesterol, triglycerides, blood sugar, and HbA1c through lifestyle modifications (diet, exercise) and potentially pharmacological interventions. Novelty: Polycystic Ovary Syndrome (PCOS) is a serious multi-organ endocrinopathy that affects not only fertility but also the overall metabolic health of the patient. Although studies have shown that the impact of PCOS on life expectancy is negligible, type of live for females with this diseases is significantly decrease due to metabolic complications complex. It is important to recognize this syndrome as early as possible, which reduces the intensity of unpleasant symptoms and prevents long-term metabolic consequences.